Literature DB >> 7024293

A comparison of indirect immunofluorescence and electron microscopy for the diagnosis of some haemorrhagic viruses in cell cultures.

A A El Mekki, G van der Groen.   

Abstract

Yellow fever, dengue (types 1, 2 and 4), Chikungunya, Rift Valley fever, Ebola, Marburg, and Lassa viruses were inoculated into susceptible cell cultures and daily investigated by indirect immunofluorescence (IFA) and electron microscopy (EM) with a view to achieve an early detection-identification of these agents. Compared to the other cell lines tested (Vero, BHK-21 and Aedes albopictus), CV-1 cells were found to be more sensitive. Viral antigens were detected by IFA from a few hours post inoculation (CHIK and RVF) to a maximum of 3 days (YF and EBO). For most of the viruses studied, the cytopathic effect (CPE) commenced 2-3 days after the detection of viral antigens. Virus particles were detected by EM only in the case of EBO, MBG and LAS, before any CPE was observed in cell cultures.

Entities:  

Mesh:

Year:  1981        PMID: 7024293     DOI: 10.1016/0166-0934(81)90002-1

Source DB:  PubMed          Journal:  J Virol Methods        ISSN: 0166-0934            Impact factor:   2.014


  3 in total

Review 1.  Ebola virus: a clear and present danger.

Authors:  Eileen M Burd
Journal:  J Clin Microbiol       Date:  2014-11-12       Impact factor: 5.948

2.  Ebolavirus delta-peptide immunoadhesins inhibit marburgvirus and ebolavirus cell entry.

Authors:  Sheli R Radoshitzky; Kelly L Warfield; Xiaoli Chi; Lian Dong; Krishna Kota; Steven B Bradfute; Jacqueline D Gearhart; Cary Retterer; Philip J Kranzusch; John N Misasi; Marc A Hogenbirk; Victoria Wahl-Jensen; Viktor E Volchkov; James M Cunningham; Peter B Jahrling; M Javad Aman; Sina Bavari; Michael Farzan; Jens H Kuhn
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

Review 3.  Baseline mapping of Lassa fever virology, epidemiology and vaccine research and development.

Authors:  Hoai J Hallam; Steven Hallam; Sergio E Rodriguez; Alan D T Barrett; David W C Beasley; Arlene Chua; Thomas G Ksiazek; Gregg N Milligan; Vaseeharan Sathiyamoorthy; Lisa M Reece
Journal:  NPJ Vaccines       Date:  2018-03-20       Impact factor: 7.344

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.